Topical Garlic Concentrate for Alopecia Areata in Children
Status:
Terminated
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Management of pediatric alopecia is particularly challenging given the chronicity of the
condition, limited therapeutic response and devastating psychological effects. There is a
paucity of safe and effective therapies in this population.
The investigators propose to conduct and open label, prospective cohort pilot study using
topical garlic concentrate ( GarlicRich) for treatment of children with alopecia areata.
Study medication will be applied topically on affected area of the skin daily for 6 months.
Follow up visits will occur monthly to access the efficacy and safety of the proposed
treatment .